Derm Cases · Dermatology / Infectious disease / Mycobacteria
OSCE — apple-jelly nodules and neck sinuses: classify and treat cutaneous tuberculosis
An 8-minute OSCE station on classifying cutaneous TB (lupus vulgaris, scrofuloderma, warty TB, tuberculids), diagnostic biopsy/AFB/PCR pathway, standard RIPE therapy, and distinguishing tuberculids (sterile skin) from true infection.
On this page
Study tools
Target exams
NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on classifying cutaneous TB (lupus vulgaris, scrofuloderma, warty TB, tuberculids), diagnostic biopsy/AFB/PCR pathway, standard RIPE therapy, and distinguishing tuberculids (sterile skin) from true infection.
Brief (to candidate)
A 40-year-old man from an endemic area has a chronic facial plaque with soft apple-jelly nodules on diascopy. A second patient has a broken-down cervical lymph node with draining sinuses. You have 8 minutes to classify cutaneous TB forms, plan investigations, start ATT, and explain tuberculids.
Candidate instructions
- Name major clinicopathologic forms: lupus vulgaris, scrofuloderma, TB verrucosa cutis, orificial/miliary, tuberculids.
- Link route of infection (exogenous / contiguous / haematogenous / hypersensitivity).
- Plan biopsy + AFB/culture/PCR and systemic TB work-up.
- Prescribe standard RIPE anti-TB therapy framework (6 months typical).
- Explain that tuberculids are sterile hypersensitivity reactions requiring treatment of the focus.
Examiner checklist (mark each domain / 10)
| Domain | Key actions expected |
|---|---|
| Lupus vulgaris | Chronic facial plaque; apple-jelly nodules on diascopy; paucibacillary; long-term SCC (Marjolin) risk in chronic plaques — biopsy change[1][2][5] |
| Scrofuloderma | Contiguous breakdown of tuberculous node/bone to skin via sinus tracts (often cervical); common cutaneous form in endemic settings[1][2] |
| Other forms | TB verrucosa cutis (warty, exogenous reinoculation in sensitised host); orificial TB (advanced internal disease); miliary cutaneous TB in immunocompromised = emergency; tuberculids (papulonecrotic, erythema induratum, lichen scrofulosorum)[1][8] |
| Work-up | Edge biopsy for granulomas (± caseation); AFB stain/culture/PCR; chest imaging and sputum as indicated; notify per public-health rules[1][5] |
| Treatment | Standard RIPE (rifampicin, isoniazid, pyrazinamide, ethambutol) ~6 months (extend selected complex cases); surgery adjunct for sinuses after medical control[5] |
| Tuberculids | Hypersensitivity to distant TB antigens; skin often culture-negative/sterile — still treat underlying TB focus with ATT, not topical steroids alone as definitive care[8] |
| Communication | Counsel adherence, hepatotoxicity monitoring concepts, and scarring/reconstruction timing after quiescence |
Model key actions
- Diagnose lupus vulgaris and scrofuloderma phenotypes and start ATT pathway.[1][5]
- Biopsy and mycobacterial work-up before or alongside treatment in non-emergency settings.[1]
- Recognise tuberculids as sterile reactive patterns needing systemic TB control.[8]
Common errors
- Treating chronic facial plaque as sarcoid/LE without mycobacterial consideration in endemic settings.
- Antibiotics alone for scrofuloderma without ATT.
- Assuming tuberculids need only topical therapy because AFB-negative.
- Missing Marjolin SCC risk in long-standing lupus vulgaris.
- Confusing paediatric scrofula from NTM adenitis (culture/PCR distinction; management may differ).
References5ShowHide
- [1]Kaul S, Kaur I, Mehta S, et al. Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features. Journal of the American Academy of Dermatology, 2023.PMID 35149149
- [2]Chen Q, Chen W, Hao F. Cutaneous tuberculosis: A great imitator. Clinics in Dermatology, 2019.PMID 31178102
- [5]Hill MK, Sanders CV. Cutaneous Tuberculosis. Microbiology Spectrum, 2017.PMID 28233513
- [8]Dhattarwal N, Ramesh V. Tuberculids: A Narrative Review. Indian Dermatology Online Journal, 2023.PMID 37266079
- [9]Gaitonde S, Pathan E, Sule A, et al. Efficacy of isoniazid prophylaxis in patients with systemic lupus erythematosus receiving long term steroid treatment Ann Rheum Dis, 2002.PMID 11830432